Overall, the first model, with an R-square of 0.23 in post-KT patients and 0.27 in dialysis patients, was statistically significant in both groups of patients and suggested that modifiable risk factors for dementia accounted for 23% and 27% of the variability in ACE III test results, respectively (Table 3). Here, ADCY3 is linked to dementia.